These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8937293)

  • 1. Ciprofloxacin for treating cholera.
    Maggi P; Carbonara S; Santantonio T; Pastore G; Angarano G
    Lancet; 1996 Nov; 348(9039):1446-7. PubMed ID: 8937293
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India.
    Krishna BV; Patil AB; Chandrasekhar MR
    Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):224-6. PubMed ID: 16246383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term quinolones for successful eradication of multiply resistant Vibrio cholerae in adult patients.
    Doğanci L; Gün H; Baysallar M; Albay A; Cinar E; Haznedaroğlu T
    Scand J Infect Dis; 1995; 27(4):425-6. PubMed ID: 8658086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral ciprofloxacin in the treatment of cholera.
    Gotuzzo E; Seas C; Echevarria J; Ruiz R; Carrillo C
    Drugs; 1995; 49 Suppl 2():451-3. PubMed ID: 8549397
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluoroquinolone resistance in Vibrio cholerae O1: emergence of El Tor Inaba.
    Das S; Goyal R; Ramachandran VJ; Gupta S
    Ann Trop Paediatr; 2005 Sep; 25(3):211-2. PubMed ID: 16156987
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial resistance surveillance of Vibrio cholerae in Thailand from 2000 to 2004.
    Supawat K; Huttayananont S; Sawanpanyalert P; Aswapokee N; Mootsikapun P
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S82-6. PubMed ID: 21294503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008.
    Ranjbar M; Rahmani E; Nooriamiri A; Gholami H; Golmohamadi A; Barati H; Rajabifar D; Barati S; Sabet MS; Zamiri A; Haghighi S; Taifehashemi P; Nojomi M
    Trop Doct; 2010 Oct; 40(4):214-6. PubMed ID: 20709810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological, clinical and therapeutic evaluation of the Italian cholera epidemic in 1994.
    Maggi P; Carbonara S; Fico C; Santantonio T; Romanelli C; Sforza E; Pastore G
    Eur J Epidemiol; 1997 Jan; 13(1):95-7. PubMed ID: 9062786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139.
    Khan WA; Bennish ML; Seas C; Khan EH; Ronan A; Dhar U; Busch W; Salam MA
    Lancet; 1996 Aug; 348(9023):296-300. PubMed ID: 8709688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-serogroup O:1 Vibrio cholerae bacteremia and cerebritis.
    Suankratay C; Phantumchinda K; Tachawiboonsak W; Wilde H
    Clin Infect Dis; 2001 Apr; 32(7):E117-9. PubMed ID: 11264049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Emerging infectious diseases--New-type cholera].
    Sagara H
    Nihon Naika Gakkai Zasshi; 1997 Nov; 86(11):2052-7. PubMed ID: 9480309
    [No Abstract]   [Full Text] [Related]  

  • 12. Vibrio cholerae 01 strain resistant to vibriostatic compound 0/129 isolated from cholera cases in Kilifi, Kenya.
    Khamala JK; Mwarumba S; Lewa P; Lowe B
    East Afr Med J; 2002 Oct; 79(10):560. PubMed ID: 12635766
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-01 Vibrio cholerae.
    Shendurnikar N
    Indian Pediatr; 1994 Jul; 31(7):869. PubMed ID: 7890360
    [No Abstract]   [Full Text] [Related]  

  • 14. [Features of Vibrio cholerae 0:1 El Tor, Inaba serotype, isolated during the cholera epidemic in Cartagena (Colombia)].
    Salim Máttar V
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):525-30. PubMed ID: 1489792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose ciprofloxacin in cholera.
    Usubütün S; Ağalar C; Diri C; Türkyilmaz R
    Eur J Emerg Med; 1997 Sep; 4(3):145-9. PubMed ID: 9426995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study to determine duration of vibrio cholerae excretion in Malawians and to test efficacy of treatment.
    Mkandawire AC
    Cent Afr J Med; 1981 Jul; 27(7):138-42. PubMed ID: 7307069
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of cholerae O-139].
    Inada H; Yamaura S; Oguchi T; Maeyama H; Ohike Y; Nakagawa M; Gibo Y
    Nihon Shokakibyo Gakkai Zasshi; 1998 Jun; 95(6):534-8. PubMed ID: 9656715
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence of fluoroquinolone resistance in strains of Vibrio cholerae isolated from hospitalized patients with acute diarrhea in Calcutta, India.
    Mukhopadhyay AK; Basu I; Bhattacharya SK; Bhattacharya MK; Nair GB
    Antimicrob Agents Chemother; 1998 Jan; 42(1):206-7. PubMed ID: 9449291
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial treatment of cholera.
    Salam MA; Khan WA; Begum M; Bardhan PK; Islam MR; Mahalanabis D
    Drugs; 1995; 49 Suppl 2():466-9. PubMed ID: 8549402
    [No Abstract]   [Full Text] [Related]  

  • 20. Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India.
    Jain M; Kumar P; Goel AK; Kamboj DV; Singh L
    Int J Antimicrob Agents; 2008 Nov; 32(5):459-60. PubMed ID: 18706789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.